lncRNA H19 Predicts Poor Prognosis in Patients With Melanoma and Regulates Cell Growth, Invasion, Migration and Epithelial–mesenchymal Transition in Melanoma Cells

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s160143
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

RACK1 Predicts Poor Prognosis and Regulates Progression of Esophageal Squamous Cell Carcinoma Through Its Epithelial-Mesenchymal Transition

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2015English

FOXN2 Is Downregulated in Breast Cancer and Regulates Migration, Invasion, and Epithelial–mesenchymal Transition Through Regulation of SLUG

Cancer Management and Research
Oncology
2019English

High PKD2 Predicts Poor Prognosis in Lung Adenocarcinoma via Promoting Epithelial–mesenchymal Transition

Scientific Reports
Multidisciplinary
2019English

Metadherin Regulates Epithelial–mesenchymal Transition in Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Tumor Budding Correlates With Poor Prognosis and Epithelial-Mesenchymal Transition in Tongue Squamous Cell Carcinoma

Journal of Oral Pathology and Medicine
Cancer ResearchOral SurgeryOtorhinolaryngologyForensic MedicinePathologyPeriodontics
2011English

H19 Contributes to Poor Clinical Features in NSCLC Patients and Leads to Enhanced Invasion in A549 Cells Through Regulating miRNA‑203‑mediated Epithelial‑mesenchymal Transition

Oncology Letters
Cancer ResearchOncology
2018English

High Expression of lncRNA PVT1 Independently Predicts Poor Overall Survival in Patients With Primary Uveal Melanoma

PLoS ONE
Multidisciplinary
2017English

High LIFr Expression Stimulates Melanoma Cell Migration and Is Associated With Unfavorable Prognosis in Melanoma

Oncotarget
Oncology
2015English

Nck2 Promotes Human Melanoma Cell Proliferation, Migration and Invasion in Vitro and Primary Melanoma-Derived Tumor Growth in Vivo

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy